Policy Integrity Updates http://policyintegrity.org Project updates from the Institute for Policy Integrity en ednai@nyu.edu Copyright 2026 2026-07-31T17:32:00+00:00 Comments to the Securities and Exchange Commission About Its Proposed Rescission of Climate-Related Financial Disclosures https://policyintegrity.org/projects/update/comments-to-the-securities-and-exchange-commission-about-its-proposed-rescission-of-climate-related-financial-disclosures policy-integrity-30986 Regulatory Process, Public Comments, SEC, 2026-08-03T18:11:00+00:00 Further Comments to UNCEEA on the Update to the System of Environmental-Economic Accounting Central Framework https://policyintegrity.org/projects/update/further-comments-to-unceea-on-the-update-to-the-system-of-environmental-economic-accounting-central-framework policy-integrity-31016 Natural Resources, Public Comments, 2026-07-31T17:32:00+00:00 Comments to the Coast Guard on Its Methodology for Estimating the Benefits of Avoiding Oil Spills https://policyintegrity.org/projects/update/comments-to-the-coast-guard-on-its-methodology-for-estimating-the-benefits-of-avoiding-oil-spills policy-integrity-30947 Climate and Energy Policy, Environmental Health, Regulatory Process, Public Comments, 2026-07-28T15:09:00+00:00 Comments to EPA on Its Proposed Maximum Containment Levels for PFAS https://policyintegrity.org/projects/update/comments-to-epa-on-its-proposed-drinking-water-standards-for-perchlorate policy-integrity-30918 Climate and Energy Policy, Public Comments, EPA, 2026-07-22T17:56:00+00:00 Amicus Brief on the FDA’s Removal of the In-Person Dispensing Requirement for Mifepristone https://policyintegrity.org/projects/update/amicus-brief-on-the-fdas-removal-of-the-in-person-dispensing-requirement-for-mifepristone policy-integrity-30917 Consumer and Healthcare Protection, Court Filings, FDA, 2026-07-22T17:02:00+00:00